Protocol: Alliance – A212102
Please Note: Below is partial eligibility, for full eligibility requirements, please contact the Genesys Hurley Cancer Institute, Research Department at (810)762-8181, (810)762-8079 and/or (810)762-8038. Thank you!
Eligibility:
Criteria for Participants with a Cancer Diagnosis
- Histologically confirmed diagnosis of invasive cancer.
- Stage I-IV.
- One of the following tumor types: Head and Neck, Hepatobiliary, Lung, Lymphoma, Leukemia, Ovary*. Pancreas*, Multiple Myeloma, Gastric, esophageal or gastroesophageal, Breast, Thyroid, Kidney*, Endometrium, Prostate, Melanoma*, Sarcoma.
- No prior definitive systemic or local anti-cancer intervention.
- Age ≥ 40 and ≤ 75.
- No known or prior history of in situ or invasive malignancy (excluding in situ nonmelanoma skin cancers) other than the current cancer diagnosis.
- No history of organ transplantation.
Criteria for Participants with a High Suspicion of Cancer
- High suspicion of ovarian cancer, pancreatic cancer, kidney cancer, or melanoma by clinical and/or radiological assessment, with plans for histologic or cytologic confirmation within 28 days after study blood draw.
- Age ≥ 40 and ≤ 75.
- No known or prior history of in situ or invasive malignancy (excluding in situ nonmelanoma skin cancers).
- No history of organ transplantation.
- Ability to read and comprehend English or Spanish.